Research

Energy balance

36.7% of adults with obesity but without diabetes had a prescription for semaglutide or tirzepatide that lasted less than 32 days.

Practitioners should be aware that a significant portion of patients may not adhere to GLP-1 RA prescriptions.

StrongSupportsmedium confidence
36.7% of the sample had a prescription that lasted <32 days (mean, 3.6 days).
Dehshini Ali et al. · Diabetes Obesity and Cardiometabolic CARE · 2026

Why this rating

Based on a retrospective cohort study design.

Source

Patterns of Prescription Discontinuation, Reinitiation, and Switching of Subcutaneous Semaglutide and Tirzepatide in Adults With Obesity

Dehshini Ali et al. · Diabetes Obesity and Cardiometabolic CARE · 2026

DOI 10.2337/doc25-0026

cohort · n=9189
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →